(Q35194202)

7 August 2017

1 reference

title

Alphavirus vectors for vaccine production and gene therapy (English)

1 reference

7 August 2017

0 references

Kenneth Lundstrom

1

1 reference

PubMed ID

12903809

7 August 2017

language of work or name

1 reference

1 June 2003

1 reference

Expert Review of Vaccines

7 August 2017

1 reference

7 August 2017

2

1 reference

7 August 2017

447-459

1 reference

7 August 2017

3

1 reference

A new generation of animal cell expression vectors based on the Semliki Forest virus replicon

7 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Sindbis virus: an efficient, broad host range vector for gene expression in animal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

In vitro synthesis of infectious venezuelan equine encephalitis virus RNA from a cDNA clone: analysis of a viable deletion mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Semliki Forest virus expression system: production of conditionally infectious recombinant particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Semliki Forest virus vectors: efficient vehicles for in vitro and in vivo gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Semliki Forest virus vectors for rapid and high-level expression of integral membrane proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Recombinant Semliki Forest virus and Sindbis virus efficiently infect neurons in hippocampal slice cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Alphavirus replicon particles as candidate HIV vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Vaccination with recombinant alphavirus or immune-stimulating complex antigen against respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Evaluation in nonhuman primates of vaccines against Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Immune protection against staphylococcal enterotoxin-induced toxic shock by vaccination with a Venezuelan equine encephalitis virus replicon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

An immunological profile of Balb/c mice protected from airborne challenge following vaccination with a live attenuated Venezuelan equine encephalitis virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Cancer therapy using a self-replicating RNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Immunization strategy against cervical cancer involving an alphavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Marked enhancement of antitumor immune responses in mouse brain tumor models by genetically modified dendritic cells producing Semliki Forest virus-mediated interleukin-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Enhancement of sindbis virus self-replicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Infection of human dendritic cells by a sindbis virus replicon vector is determined by a single amino acid substitution in the E2 glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Noncytopathic Sindbis virus RNA vectors for heterologous gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

A temperature-regulated replicon-based DNA expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Replicon vectors derived from Sindbis virus and Semliki forest virus that establish persistent replication in host cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Novel Semliki Forest virus vectors with reduced cytotoxicity and temperature sensitivity for long-term enhancement of transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Semliki Forest virus A7(74) transduces hippocampal neurons and glial cells in a temperature-dependent dual manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Layered amplification of gene expression with a DNA gene delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Comparative analysis of humoral immune responses to HIV type 1 envelope glycoproteins in mice immunized with a DNA vaccine, recombinant Semliki Forest virus RNA, or recombinant Semliki Forest virus particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Recombinant Semliki Forest virus vector exhibits potential for avian virus vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Enhancing immune responses using suicidal DNA vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Influenza virus (A/HK/156/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Self-replicating Semliki Forest virus RNA as recombinant vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Marburg virus vaccines: comparing classical and new approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.445

21 January 2018

Identifiers

DOI

10.1586/14760584.2.3.445

1 reference

7 August 2017

1 reference

PubMed ID

12903809